|Bid||0.00 x 1100|
|Ask||0.00 x 2900|
|Day's Range||21.88 - 22.17|
|52 Week Range||17.31 - 24.95|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||410.00|
|Forward Dividend & Yield||1.80 (8.17%)|
|Ex-Dividend Date||Nov 12, 2019|
|1y Target Est||N/A|
Is Sabra Health Care REIT Inc (NASDAQ:SBRA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial […]
When looking for the best dividend stocks, don't ignore REITs. A stable economy and yields that beat U.S. Treasuries make them attractive moneymakers.
For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...
Sabra (SBRA) delivered FFO and revenue surprises of 2.17% and -2.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of June 28. In this […]
This Louisville-based provider will double the number of its facilities and expand into new markets through a deal it struck a deal with a huge national development company.
Is Sabra Health Care REIT, Inc. (NASDAQ:SBRA) a good dividend stock? How can we tell? Dividend paying companies with...
Sabra Health Care (SBRA) restates unsecured credit facility aggregating $2.2 billion, which will improve its debt maturities laddering. The company has no significant expirations until 2022.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
It looks like Sabra Health Care REIT, Inc. (NASDAQ:SBRA) is about to go ex-dividend in the next 4 days. Ex-dividend...
Sabra (SBRA) delivered FFO and revenue surprises of -2.13% and 35.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Sabra Health Care REIT, Inc. New York, July 30, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Sabra Health Care REIT, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
If you're interested in Sabra Health Care REIT, Inc. (NASDAQ:SBRA), then you might want to consider its beta (a...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Sabra (SBRA) delivered FFO and revenue surprises of -4.00% and -5.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif. (AP) _ Sabra Healthcare REIT Inc. (SBRA) on Wednesday reported a key measure of profitability in its first quarter. The results did not meet Wall Street expectations. The real estate investment trust, based in Irvine, California, said it had funds from operations of $85.4 million, or 48 cents per share, in the period.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! I've been keeping an eye on Sabra Health Care REIT, Inc. (NASDAQ:SBRA) because I'm attracted...
Is Sabra Health Care REIT Inc (NASDAQ:SBRA) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for […]